MOH — authorised 27 January 2006
- Marketing authorisation holder: GILEAD
- Status: likely_approved
MOH authorised Ranexa on 27 January 2006
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 27 January 2006.
GILEAD holds the Israeli marketing authorisation.